Market Overview

Oncolytics Closes Offering of 8M Shares at $4/Share for Gross Proceeds of $32M

Related ONCY
US Stock Futures Up Ahead Of Auto Sales, Construction Spending Data
Stocks Hitting 52-Week Lows

Oncolytics Biotech Inc. (NASDAQ: ONCY) announced today that it has closed its previously announced underwritten public offering of 8.0 million common shares, at a public offering price of US$4.00 per common share.  The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses payable by Oncolytics, were approximately US$32.0 million.

Posted-In: News Offerings

 

Related Articles (ONCY)

Around the Web, We're Loving...

Get Benzinga's Newsletters